Summary of NICE guidance for Spondyloarthritis

Karoline Brennan, Senior Medicines Information Pharmacist, North West Medicines Information CentrePublished

This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this guideline.

NICE Bites is a monthly prescribing bulletin from the North West Medicines Information Centre which summarises key prescribing points from NICE guidance.  NICE Bites No 95, March 2017 includes one topic: Spondyloarthritis in over 16s – diagnosis and management (NICE NG65).

Sections covered include: recognition and diagnosis, referral criteria, treatment and management, axial spondyloarthritis – non-pharmacological treatment, pharmacological treatment (NSAIDs, TNF-alpha inhibitors, secukinumab), peripheral spondyloarthritis – pharmacological treatment (DMARDs, NSAIDs, apremilast, TNF-alpha inhibitors, ustekinumab), reactive arthritis, managing flares, managing long-term complications, referral for surgery, and coordinating care.

Attachments